- Home
- ALAB
ALAB
ASTERA LABS INC
as 01-21-2025 4:00pm EST
Stocks
Astera Labs Inc is a company that offers an Intelligent Connectivity Platform, comprised of Semiconductor-based, high-speed mixed-signal connectivity products that integrate a matrix of microcontrollers and sensors. COSMOS, their software suite which is embedded in its connectivity products and integrated into their customers' systems. The Company delivers critical connectivity performance, enables flexibility and customization, and supports observability and predictive analytics. This approach addresses the data, network, and memory bottlenecks, scalability, and other infrastructure requirements of hyperscalers and system original equipment manufacturers.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | SANTA CLARA |
| Market Cap: | 22.4B | IPO Year: | 2024 |
| Target Price: | $108.08 | AVG Volume (30 days): | 3.7M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.93 | EPS Growth: | N/A |
| 52 Week Low/High: | $36.22 - $147.39 | Next Earning Date: | 02-10-2025 |
| Revenue: | $305,708,000 | Revenue Growth: | 282.75% |
| Revenue Growth (this year): | 235.35% | Revenue Growth (next year): | 60.00% |
Stock Insider Trading Activity of ASTERA LABS INC (ALAB)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| ALBA MANUEL | ALAB | Director | Dec 4 '24 | Sell | $118.18 | 11,000 | $1,292,531.46 | 2,064,498 | |
| Tate Michael Truett | ALAB | Chief Financial Officer | Dec 4 '24 | Sell | $118.08 | 16,000 | $1,885,472.22 | 1,425,266 | |
| ALBA MANUEL | ALAB | Director | Dec 2 '24 | Sell | $109.20 | 126,000 | $13,593,864.76 | 2,064,498 | |
| Tate Michael Truett | ALAB | Chief Financial Officer | Dec 2 '24 | Sell | $109.66 | 334,000 | $36,121,215.32 | 1,425,266 | |
| HURLSTON MICHAEL E. | ALAB | Director | Nov 27 '24 | Sell | $101.06 | 67,453 | $6,732,931.81 | 97,379 | |
| Mohan Jitendra | ALAB | Chief Executive Officer | Nov 25 '24 | Sell | $110.12 | 173,366 | $19,091,427.99 | 4,442,603 | |
| Dyckerhoff Stefan A | ALAB | Director | Nov 22 '24 | Sell | $106.02 | 45,629 | $4,852,010.24 | 3,765 | |
| Mohan Jitendra | ALAB | Chief Executive Officer | Nov 21 '24 | Sell | $103.53 | 171,064 | $17,711,059.92 | 4,442,603 | |
| Dyckerhoff Stefan A | ALAB | Director | Nov 18 '24 | Sell | $92.91 | 203,445 | $18,443,275.60 | 3,765 | |
| Tate Michael Truett | ALAB | Chief Financial Officer | Nov 18 '24 | Sell | $90.81 | 7,398 | $671,833.83 | 1,425,266 |
Latest ASTERA LABS INC News
ALAB Breaking Stock News: Dive into ALAB Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
Three US Growth Companies With Significant Insider Ownership
Investor's Business Daily
4 days ago
Hot AI Chip Stock Astera Labs Looks To Reignite Rally At A Key Support Level
Simply Wall St.
6 days ago
Astera Labs, Inc. (NASDAQ:ALAB) is largely controlled by institutional shareholders who own 43% of the company
GlobeNewswire
12 days ago
Astera Labs Announces Conference Call to Review Fourth Quarter 2024 Financial Results
Investor's Business Daily
14 days ago
Amazon, Google Power These Best IPOs 2024 To New Highs; Reddit Trounces Palantir
TipRanks
19 days ago
Astera Labs downgraded at Northland after 300% advance since IPO
Investor's Business Daily
25 days ago
Palantir, AppLovin Among The 100 Best Stocks Of 2024
Investor's Business Daily
25 days ago
IPO Stock Roundup: Astera, Reddit Hit New Highs; Atour, Oddity Trigger Sell Signals
Compare ALAB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ALAB ASTERA LABS INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.